The Europe Bunion Correction Systems Market would witness market growth of 6.9% CAGR during the forecast period (2022-2028).
It is anticipated that changing lifestyles and an increase in the working population in both developed and emerging nations will support market expansion. Other significant reasons that are projected to drive the market growth include the increasing prevalence of arthritis in the world's population and the use of improperly fitting shoes, which results in foot anatomical deformities.
Bunions can be linked to various types of arthritis, particularly inflammatory arthritis like rheumatoid arthritis. Inflammation in the joints brought on by rheumatoid arthritis raises the possibility of developing a bunion.
Bunion correction systems usually consist of a splint that's worn over the big toe and an adjustable strap that helps to realign the toe. They're easy to use and can be worn during the day or at night. Bunion correction systems are becoming increasingly popular in Europe as more and more people look to correct the deformity. Germany, Spain, and the UK are leading the way in terms of bunion correction procedures, with France not far behind.
The Germany market dominated the Europe Bunion Correction Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $67.3 million by 2028. The UK market is anticipated to grow at a CAGR of 6% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.7% during (2022 - 2028).
Based on Product, the market is segmented into Wearables and Implants & Accessories. Based on End-Use, the market is segmented into Hospitals, Ambulatory Centers, and Specialty Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Bunion Correction Systems Market will Hit $1.1 Billion by 2028, at a CAGR of 7.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Arthrex, Inc., Zimmer Biomet Holdings, Inc., Extremity Medical, LLC., Acumed, LLC., De Puy Synthes (Johnson & Johnson), BioPro, Inc., and Orthofix Medical, Inc.
By Product
By End Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.